Hannibal Regional Medical Group Plastic Surgeon First In Area To Offer New
Breast Implant Option
HANNIBAL, Mo., March 1, 2013
HANNIBAL, Mo., March 1, 2013 /PRNewswire-USNewswire/ --After several years of
clinical studies, Allergan, Inc. today announced that the company has received
approval from the U.S. Food and Drug Administration (FDA) to market the
Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast
Implants for use in breast reconstruction, augmentation and revision surgery.
Dr. Schuyler C. Metlis, board certified plastic surgeon with Hannibal
Regional Medical Group, is one of only approximately 125 plastic surgeons in
the country who have used this implant, after being involved in the clinical
"The FDA approval of Natrelle® 410 shaped gel implants provides an important
new alternative to traditional round implants for women considering breast
augmentation, reconstruction or revision surgery," said David E.I. Pyott,
Allergan's Chairman of the Board, President and Chief Executive Officer.
"Due to my participation for the past 7½ years in the study of this superior
latest generation cohesive gel implant, I am sure that women will be very
pleased with their surgical results," said Dr. Metlis.
The Natrelle® 410 shaped gel implant is designed to mimic the slope of the
breast and is filled with a highly cohesive silicone gel, which is intended to
enable the implant to hold its shape over time while remaining soft to the
To schedule an appointment with Dr. Metlis to see if you are a candidate for
this new product, call 573-629-3500. For more information, visit
SOURCE Hannibal Regional Medical Group
Contact: Tracy Fountain, +1-573-629-3569, firstname.lastname@example.org
Press spacebar to pause and continue. Press esc to stop.